🧠 Neurological Disorder

Distal Spinal Muscular Atrophy

Also known as: dSMA, Distal SMA, Hereditary Motor Neuropathy, Distal Type

Distal spinal muscular atrophy (dSMA) comprises a group of rare genetic disorders characterized by progressive muscle weakness and wasting (atrophy) primarily affecting the distal muscles of the limbs (hands and feet). Different forms of dSMA exist, each with varying genetic causes, age of onset, and severity. The condition is caused by the degeneration of motor neurons in the spinal cord, which control voluntary muscle movement.

👥 Rare (estimated 1-9 / 1,000,000) Prevalence
🔬 5 Active Trials

Imagine your muscles are like tiny workers that help you move. In dSMA, the workers in your hands and feet get tired and weak, making it hard to do things like write or walk. Doctors try to help by giving you special exercises and tools to make things easier.

Signs & Symptoms

  • Distal muscle weakness (hands and feet)
  • Muscle atrophy
  • Foot deformities (e.g., pes cavus)
  • Hand deformities (e.g., claw hand)
  • Progressive motor impairment
  • Sensory abnormalities (in some subtypes)
  • Tremors (in some subtypes)
  • Respiratory muscle weakness (in severe cases)

Treatment Options

THERAPY

Physical Therapy

SUPPORTIVE
THERAPY

Occupational Therapy

SUPPORTIVE
SUPPORTIVE

Orthotics and Assistive Devices

SUPPORTIVE
SUPPORTIVE

Respiratory Support (if needed)

SUPPORTIVE
SUPPORTIVE

Nutritional Support

SUPPORTIVE
GENE THERAPY

Gene Therapy (experimental)

EXPERIMENTAL

Diagnosis

  • Clinical examination
  • Electromyography (EMG)
  • Nerve conduction studies
  • Muscle biopsy
  • Genetic testing (to identify specific gene mutations)

History

Distal spinal muscular atrophies have been recognized as distinct entities within the broader spectrum of motor neuron diseases for several decades. Initial descriptions focused on clinical phenotypes, with subsequent advances in genetics leading to the identification of specific gene mutations responsible for different subtypes.

Recent Breakthroughs

2022

Gene Therapy Approaches for dSMA

Early-stage research is exploring gene therapy strategies to deliver functional copies of mutated genes in specific dSMA subtypes. Preclinical studies have shown promising results in animal models.

2023

Identification of Novel Genetic Mutations

Ongoing genetic research continues to identify novel mutations associated with dSMA, improving diagnostic capabilities and expanding our understanding of the disease's genetic landscape.